Replies to post #3632 on PharmaRoth Labs, Inc. (ROTH)

[Jayyy]

In 2013 ROTH submitted its NDI to FDA. The FDA objected to this filing stating it was a drug not a supplement and should go the Investigational New Drug route. ROTH has done NONE of this as the original filing was just to get a press release that they did file.